Inmune Bio Inc (INMB)

Oct 23, 2026

Could Drug Research Partnership Just Shift Quantum Computing's (QUBT) Investment Narrative? - Simply Wall Street

Oct 23, 2026

Oct 22, 2026

Alzheimer's Disease Clinical Trial and Competitive Landscape Enters a New Phase as 200+ Companies Advance Clinical Programs | DelveInsight - GlobeNewswire Inc.

Oct 22, 2026

Oct 21, 2026

Form 4 Palisade Bio Inc: Julien E. Capers (Officer) For: 19 October - Investing.com UK

Oct 21, 2026

Oct 21, 2026

Form 8K INmune Bio Inc For: 21 October By Investing.com - Investing.com South Africa

Oct 21, 2026

Oct 21, 2026

UK approval could come about six weeks earlier, Inmune Bio (INMB) says of its revised Ebstrocel plan. - Stock Titan

Oct 21, 2026

Oct 21, 2026

A treatment for children with a skin disease could gain UK approval about six weeks sooner. - Stock Titan

Oct 21, 2026

Oct 21, 2026

Doctors may be able to request INmune Bio’s experimental cell therapy before local approval. - Stock Titan

Oct 21, 2026

Oct 15, 2026

Quantum Technology Meets Biotechnology: INmune Bio and Quantum Computing Inc. Team Up to Accelerate Drug Discovery - TheStreet

Oct 15, 2026

Oct 14, 2026

A quantum-computing company gets its first customer in pharma and biotech: INmune Bio - Stock Titan

Oct 14, 2026

Oct 12, 2026

Full Transcript: INmune Bio Q2 2026 Earnings Call - Benzinga

Oct 12, 2026

Oct 09, 2026

TRex Bio, Inc. Common stock (TRXB) company profile and facts - Yahoo Finance UK

Oct 09, 2026

Oct 08, 2026

TRex Bio, Inc. Common stock (TRXB) stock price, news, quote and history - Yahoo Finance UK

Oct 08, 2026

Oct 07, 2026

INmune Bio stock heads into Maxim summit before Q3 results - AD HOC NEWS

Oct 07, 2026

Oct 01, 2026

Quantum Computing Inc. Announces Dirac-3S, Scaling to Nearly 10,000 Variables - Stock Titan

Oct 01, 2026

Sep 23, 2026

Form 4 INmune Bio Inc For: 23 September - Investing.com India

Sep 23, 2026

Sep 23, 2026

Form 4 INmune Bio Inc For: 23 September By Investing.com - Investing.com Canada

Sep 23, 2026

Sep 23, 2026

Form 4 INmune Bio Inc For: 23 September By Investing.com - Investing.com UK

Sep 23, 2026

Sep 23, 2026

Inmune Bio (INMB) gives director 3-year option grant - Stock Titan

Sep 23, 2026

Sep 18, 2026

Inmune Stock Price Forecast. Should You Buy INMB? - StockInvest.us

Sep 18, 2026

Sep 17, 2026

Inmune Bio (NASDAQ: INMB) grants 100,000 stock options to new director - Stock Titan

Sep 17, 2026

Sep 14, 2026

A Sanofi rare-disease leader joins INmune Bio's board for a possible treatment launch. - Stock Titan

Sep 14, 2026

Sep 09, 2026

INmune Bio to Present at the H.C. Wainwright Global Investment Conference - Yahoo Finance

Sep 09, 2026

Aug 31, 2026

Inmune Bio stock steadies as investors await next data catalyst - ad-hoc-news.de

Aug 31, 2026

Aug 28, 2026

INmune Bio undervalued as Ebstrocel for RDEB ne... - Pluang

Aug 28, 2026

Aug 28, 2026

INmune Bio: CORDStrom In The Lead After Signs Of UK Regulatory Alignment (NASDAQ:INMB) - Seeking Alpha

Aug 28, 2026

Aug 27, 2026

aTyr Pharma And 2 Other Penny Stocks With Promising Potential - Sahm

Aug 27, 2026

Aug 26, 2026

aTyr Pharma And 2 Other Penny Stocks With Promising Potential - simplywall.st

Aug 26, 2026

Aug 26, 2026

INmune Bio submits EU regulatory filings for Ebstrocel in RDEB By Investing.com - Investing.com Canada

Aug 26, 2026

Aug 26, 2026

INmune Bio submits EU regulatory filings for Ebstrocel in RDEB By Investing.com - Investing.com India

Aug 26, 2026

Aug 26, 2026

INmune Bio Advances Ebstrocel™ Toward European Marketing Authorization with EMA Regulatory Filings - Yahoo Finance

Aug 26, 2026

Aug 26, 2026

INmune Bio submits EU regulatory filings for Ebstrocel in RDEB - Investing.com

Aug 26, 2026

Aug 24, 2026

INmune (INMB) Financial Results: EPS Comes in Above Forecast on the Day; Post-Earnings: The Stock Gains 1.72% in the Latest ReadingEarnings Analysis - dars.gov.et

Aug 24, 2026

Aug 15, 2026

INmune Bio (INMB) Climbs 4.33% to $2.17 as Traders Test Key Resistance at $2.28Put Spread Alert - dars.gov.et

Aug 15, 2026

Aug 14, 2026

Climb Bio, Inc. (CLYM): MPM BioImpact LLC reports 0% ownership in amendment - Stock Titan

Aug 14, 2026

Aug 13, 2026

INmune Bio Inc (INMB) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey

Aug 13, 2026

Aug 08, 2026

INmune Bio Advances Ebstrocel Regulatory Filings and Clinical Plans - sekbernews.id

Aug 08, 2026

Aug 08, 2026

INmune Bio (NASDAQ:INMB) Upgraded by Wall Street Zen to "Hold" Rating - MarketBeat

Aug 08, 2026

Aug 08, 2026

Q2 2026 INmune Bio Inc Earnings Call Transcript - GuruFocus

Aug 08, 2026

Aug 07, 2026

Earnings call transcript: INmune Bio posts narrower Q2 2026 loss, eyes filings - Investing.com South Africa

Aug 07, 2026

Aug 07, 2026

Earnings call transcript: INmune Bio posts narrower Q2 2026 loss, eyes filings - Investing.com Nigeria

Aug 07, 2026

Aug 07, 2026

INmune Bio (INMB) Q2 2026 Earnings Call Transcript - AOL.com

Aug 07, 2026

Aug 07, 2026

INmune Bio Inc (INMB) (Q2 2026) Earnings Call Highlights: Regula - GuruFocus

Aug 07, 2026

Aug 07, 2026

INmune Bio (INMB) Q2 2026 Earnings Call Transcript - The Globe and Mail

Aug 07, 2026

Aug 07, 2026

INmune Bio Inc (INMB) (Q2 2026) Earnings Call Highlights: Regulatory Wins and Strategic Focus ... - Yahoo Finance

Aug 07, 2026

Aug 07, 2026

INmune Bio, Inc. Q2 2026 Earnings Call Summary - Yahoo Finance

Aug 07, 2026

Aug 06, 2026

INmune Bio Q2 Earnings Call Highlights - MarketBeat

Aug 06, 2026

Aug 06, 2026

Earnings call transcript: INmune Bio posts narrower Q2 2026 loss, eyes filings - Investing.com

Aug 06, 2026

Aug 06, 2026

INmune Bio Q2 2026 Earnings: Tax-Credit Benefit Narrows Net Loss - TradingKey

Aug 06, 2026

Aug 06, 2026

INmune Bio (NASDAQ:INMB) Releases Quarterly Earnings Results, Beats Expectations By $0.16 EPS - MarketBeat

Aug 06, 2026

Aug 06, 2026

INMB: Ebstrocel nears global filings as financials strengthen and XPro advances in Alzheimer's - TradingView

Aug 06, 2026